Age-related Variation in Expression of Breast Cancer Tumour Markers in Iranian Patients

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 58

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MISJ-12-2_013

تاریخ نمایه سازی: 25 آبان 1402

Abstract:

Background: There are believed to be several risk factors affecting the prognosis of breast cancer through their effect on the growth rate of tumour. In the present study, we investigated estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor ۲ (HER۲), Ki-۶۷, and tumor protein P۵۳ (TP۵۳) as well-known biomarkers, particularly in breast cancer prognosis, associated with age. Method: In a case-control study, ۴۰۶ breast cancer patients were considered retrospectively. In order to extract the clinical and pathologic data, we employed the patients’ records. The extracted information was compared between two groups: for patients under ۴۰ (group I) and above ۴۰ years of age (group II). Herein, the researchers performed statistical analysis using SPSS Ver۱۶. Results: The most prevalent type of cancer in both groups was found to be invasive ductal carcinoma. The major method of treatment was modified radical mastectomy. According to our observations, grade ۳ breast cancer was more common in group I. Lymph node involvement significantly increased in group I, while oestrogen and progesterone receptor expressions were less in this group. HER۲, TP۵۳, and Ki-۶۷ oncogenes were overexpressed in group I compared with group II. Conclusion: Expression of HER۲, TP۵۳, and Ki-۶۷ biomarkers and a reduction in the number of hormonal receptors in younger patients (<۴۰YO) indicated that breast cancer might be more invasive in younger women with breast cancer and therefore, they might have poorer prognosis and less favourable outcomes.

Authors

Fatemeh Homaei Shandiz

Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Fahimeh Afzaljavan

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Amir Tajbakhsh

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Rivadeh

Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Nourieh Sharifi

Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Taghi Shakeri

Department of Biostatistics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Alireza Pasdar

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran